Chemoinformaics analysis of 6,6-Dimethyl-2-methylenebicyclo[3.1.1]hept-3-yl acetate
Molecular Weight | 194.274 | nRot | 1 |
Heavy Atom Molecular Weight | 176.13 | nRig | 14 |
Exact Molecular Weight | 194.131 | nRing | 3 |
Solubility: LogS | -3.575 | nHRing | 0 |
Solubility: LogP | 3.153 | No. of Aliphatic Rings | 3 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 3 |
Atoms Count | 32 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 14 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 2 | No. Saturated Carbocycles | 3 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 12 | No. of Saturated Rings | 3 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 33.6463 |
nHD | 0 | BPOL | 20.6617 |
QED | 0.655 |
Synth | 2.147 |
Natural Product Likeliness | 0.785 |
NR-PPAR-gamma | 0.828 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.006 |
Pgp-sub | 0.023 |
HIA | 0.009 |
CACO-2 | -4.83 |
MDCK | 0.000014 |
BBB | 0.104 |
PPB | 0.997316 |
VDSS | 0.513 |
FU | 0.0115816 |
CYP1A2-inh | 0.967 |
CYP1A2-sub | 0.909 |
CYP2c19-inh | 0.797 |
CYP2c19-sub | 0.118 |
CYP2c9-inh | 0.664 |
CYP2c9-sub | 0.951 |
CYP2d6-inh | 0.617 |
CYP2d6-sub | 0.914 |
CYP3a4-inh | 0.879 |
CYP3a4-sub | 0.264 |
CL | 12.496 |
T12 | 0.856 |
hERG | 0.098 |
Ames | 0.749 |
ROA | 0.711 |
SkinSen | 0.934 |
Carcinogencity | 0.642 |
EI | 0.967 |
Respiratory | 0.799 |
NR-Aromatase | 0.789 |
Antiviral | No |
Prediction | 0.609036 |